| 1 | [SID48414954] | Active | | | DSSTox (EPAFHM) EPA Fathead Minnow Acute Toxicity [AID1188, Type: other] | |  View X | Row No. | 1 | | Structure | 
| | Substance | | | SID | 48414954 | | CID | 6568 | | Outcome | Active | | BioAssay | DSSTox (EPAFHM) EPA Fathead Minnow Acute Toxicity | | AID | 1188 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 2 | [SID103226169] | Unspecified | | | Toxicity determined using Golden Orfe Fish Test [AID101345, Type: Literature] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103226169 | | CID | 6568 | | Outcome | Unspecified | | BioAssay | Toxicity determined using Golden Orfe Fish Test | | AID | 101345 | | BioAssay type | Literature | | Target | | | PubMed | 2033592 | | Data Table | |
|
| 3 | [SID103226169] | Unspecified | | | Toxicity determined using Tadpole Narcosis Test [AID212400, Type: Literature] | | View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103226169 | | CID | 6568 | | Outcome | Unspecified | | BioAssay | Toxicity determined using Tadpole Narcosis Test | | AID | 212400 | | BioAssay type | Literature | | Target | | | PubMed | 2033592 | | Data Table | |
|
| 4 | [SID103226169] | Unspecified | | | Binding affinity to beta cyclodextrin [AID346025, Type: Literature] | | View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103226169 | | CID | 6568 | | Outcome | Unspecified | | BioAssay | Binding affinity to beta cyclodextrin | | AID | 346025 | | BioAssay type | Literature | | Target | | | PubMed | 19056282 | | Data Table | |
|
| 5 | [SID17389639] | Unspecified | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other] | | View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Unspecified | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table | |
|
| 6 | [SID17389639] | Inactive | Potency | 7.9433 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table | |
|
| 7 | [SID17389639] | Inactive | Potency | 7.9433 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table | |
|
| 8 | [SID17389639] | Inactive | Potency | 7.9433 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table | |
|
| 9 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule antagonists of vitamin D receptor signaling [AID588541, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of vitamin D receptor signaling | | AID | 588541 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table | |
|
| 10 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule antagonists of vitamin D receptor signaling [AID588541, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of vitamin D receptor signaling | | AID | 588541 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table | |
|
| 11 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule antagonists of vitamin D receptor signaling [AID588541, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of vitamin D receptor signaling | | AID | 588541 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table | |
|
| 12 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule antagonists of vitamin D receptor signaling [AID588541, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of vitamin D receptor signaling | | AID | 588541 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table | |
|
| 13 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule agonists of vitamin D receptor signaling [AID588543, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of vitamin D receptor signaling | | AID | 588543 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table | |
|
| 14 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule agonists of vitamin D receptor signaling [AID588543, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of vitamin D receptor signaling | | AID | 588543 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table | |
|
| 15 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule agonists of vitamin D receptor signaling [AID588543, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of vitamin D receptor signaling | | AID | 588543 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table | |
|
| 16 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule agonists of vitamin D receptor signaling [AID588543, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of vitamin D receptor signaling | | AID | 588543 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table | |
|
| 17 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule antagonists of farnesoid X receptor signaling [AID588526, Type: confirmatory] | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of farnesoid X receptor signaling | | AID | 588526 | | BioAssay type | confirmatory | | Target | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | | PubMed | | | Data Table | |
|
| 18 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule antagonists of farnesoid X receptor signaling [AID588526, Type: confirmatory] | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of farnesoid X receptor signaling | | AID | 588526 | | BioAssay type | confirmatory | | Target | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | | PubMed | | | Data Table | |
|
| 19 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule antagonists of farnesoid X receptor signaling [AID588526, Type: confirmatory] | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of farnesoid X receptor signaling | | AID | 588526 | | BioAssay type | confirmatory | | Target | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | | PubMed | | | Data Table | |
|
| 20 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule antagonists of farnesoid X receptor signaling [AID588526, Type: confirmatory] | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of farnesoid X receptor signaling | | AID | 588526 | | BioAssay type | confirmatory | | Target | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | | PubMed | | | Data Table | |
|
| 21 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule agonists of farnesoid X receptor signaling [AID588527, Type: confirmatory] | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of farnesoid X receptor signaling | | AID | 588527 | | BioAssay type | confirmatory | | Target | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | | PubMed | | | Data Table | |
|
| 22 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule agonists of farnesoid X receptor signaling [AID588527, Type: confirmatory] | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of farnesoid X receptor signaling | | AID | 588527 | | BioAssay type | confirmatory | | Target | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | | PubMed | | | Data Table | |
|
| 23 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule agonists of farnesoid X receptor signaling [AID588527, Type: confirmatory] | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of farnesoid X receptor signaling | | AID | 588527 | | BioAssay type | confirmatory | | Target | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | | PubMed | | | Data Table | |
|
| 24 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule agonists of farnesoid X receptor signaling [AID588527, Type: confirmatory] | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of farnesoid X receptor signaling | | AID | 588527 | | BioAssay type | confirmatory | | Target | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | | PubMed | | | Data Table | |
|
| 25 | [SID17389639] | Inactive | Potency | | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table | |
|
| 26 | [SID17389639] | Inactive | Potency | | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table | |
|
| 27 | [SID17389639] | Inactive | | | JNK3 AlphaScreen Assay [AID530, Type: confirmatory] | Mitogen-activated protein kinase 10 (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase [gi:2499604] | View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | BioAssay | JNK3 AlphaScreen Assay | | AID | 530 | | BioAssay type | confirmatory | | Target | Mitogen-activated protein kinase 10 (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase [gi:2499604] | | PubMed | | | Data Table | |
|
| 28 | [SID17389639] | Inactive | Potency | | qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium [AID1457, Type: confirmatory] | Inositol monophosphatase [gi:44888968] | View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium | | AID | 1457 | | BioAssay type | confirmatory | | Target | Inositol monophosphatase [gi:44888968] | | PubMed | | | Data Table | |
|
| 29 | [SID17389639] | Inactive | Potency | | qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium [AID1457, Type: confirmatory] | Inositol monophosphatase [gi:44888968] | View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium | | AID | 1457 | | BioAssay type | confirmatory | | Target | Inositol monophosphatase [gi:44888968] | | PubMed | | | Data Table | |
|
| 30 | [SID17389639] | Inactive | Potency | | qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway [AID651751, Type: confirmatory] | pregnane X receptor [Rattus norvegicus] [gi:5702233] | View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway | | AID | 651751 | | BioAssay type | confirmatory | | Target | pregnane X receptor [Rattus norvegicus] [gi:5702233] | | PubMed | | | Data Table | |
|
| 31 | [SID17389639] | Inactive | Potency | | qHTS Assay for Anthrax Lethal Toxin Internalization [AID912, Type: confirmatory] | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] | View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Anthrax Lethal Toxin Internalization | | AID | 912 | | BioAssay type | confirmatory | | Target | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] | | PubMed | | | Data Table | |
|
| 32 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-005 [AID967, Type: confirmatory] | | View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-005 | | AID | 967 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 33 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-009 [AID968, Type: confirmatory] | | View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-009 | | AID | 968 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 34 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-011 [AID969, Type: confirmatory] | | View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-011 | | AID | 969 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 35 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-013 [AID970, Type: confirmatory] | | View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-013 | | AID | 970 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 36 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-015 [AID971, Type: confirmatory] | | View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-015 | | AID | 971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 37 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-017 [AID972, Type: confirmatory] | | View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-017 | | AID | 972 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 38 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-019 [AID973, Type: confirmatory] | | View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-019 | | AID | 973 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 39 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-021 [AID974, Type: confirmatory] | | View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-021 | | AID | 974 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 40 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-023 [AID975, Type: confirmatory] | | View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-023 | | AID | 975 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 41 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-025 [AID976, Type: confirmatory] | | View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-025 | | AID | 976 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 42 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-002 [AID977, Type: confirmatory] | | View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-002 | | AID | 977 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 43 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-006 [AID978, Type: confirmatory] | | View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-006 | | AID | 978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 44 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-007 [AID979, Type: confirmatory] | | View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-007 | | AID | 979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 45 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-008 [AID980, Type: confirmatory] | | View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-008 | | AID | 980 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 46 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-010 [AID981, Type: confirmatory] | | View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-010 | | AID | 981 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 47 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-012 [AID982, Type: confirmatory] | | View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-012 | | AID | 982 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 48 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-014 [AID983, Type: confirmatory] | | View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-014 | | AID | 983 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 49 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-016 [AID984, Type: confirmatory] | | View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-016 | | AID | 984 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
| 50 | [SID17389639] | Inactive | Potency | | Cell Viability - LYMP2-018 [AID985, Type: confirmatory] | | View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17389639 | | CID | 6568 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Cell Viability - LYMP2-018 | | AID | 985 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table | |
|
Chemical Probe 
Active 
Inactive 
Inconclusive 
Unspecified 
